OPTIMIZERx Corporation Announces Partnership With HealthTronics to Deliver Patient Savings and Support
30 Juli 2013 - 2:00PM
Marketwired
OPTIMIZERx Corp. (OTCQB: OPRX) today announced a new alliance,
expanding the delivery of its SampleMD solution to an important
physician specialty group.
HealthTronics, a part of Endo Health Solutions, is a urology
solutions company built by urologists to deliver better patient
care, better economics, and better outcomes. The HealthTronics EHR
solutions were designed by practicing urologists to optimize
patient care, while serving the specific needs of urology health
professionals.
"We are extremely pleased to be able to partner with
HealthTronics to deliver SampleMD's eCoupon and eVoucher solutions
to HealthTronics' urologist members, right within their
e-Prescribing workflow," said Shad Stastney, Chairman and CEO of
OptimizeRx. "By making the ever-increasing menu of urology-focused
treatments more affordable for patients, the SampleMD solution
improves adherence and outcomes, while at the same time offering
important value for our pharmaceutical and EHR clients."
The SampleMD solution will be integrated within the
HealthTronics UroChartEHR and meridianEMR solutions.
For more information, please go to www.samplemd.com or contact
us at 248-651-6568.
About OptimizeRx Corp OPTIMIZERx Corp.
(OTCQB: OPRX) provides unique consumer and physician platforms to
help patients better afford and comply with their medicines and
healthcare products, while offering pharmaceutical and healthcare
companies effective ways to expand patient awareness, access and
adherence to their medications. For more information, please go to
www.samplemd.com.
'SAFE HARBOR' This press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended and such section 21E of the Securities Act
of 1934, amended. These forward-looking statements should not be
used to make an investment decision. The words 'estimate,'
'possible' and 'seeking' and similar expressions identify
forward-looking statements, which speak only as to the date the
statement was made. The company undertakes no obligation to
publicly update or revise any forward-looking statements, whether
because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition and other material risks.
Contact: Gabrielle Sabatini Email Contact 248-651-6568
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024